| For: | Tonini V, Zanni M. Pancreatic cancer in 2025: Have we found a solution? World J Gastroenterol 2025; 31(43): 111433 [PMID: 41358172 DOI: 10.3748/wjg.v31.i43.111433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i43/111433.htm |
| Number | Citing Articles |
| 1 |
Yanzhao Mao, Yuqi Zhang, Yupeng Zhang, Dongwei Lin, Yuelin Song, Xiaojiang Niu, Peihao Xv, Yuliang Wang, Zhigang Wei. Unraveling the roles of DKK1 and S100P in pancreatic ductal adenocarcinoma: Insights from machine learning, single-cell/spatial transcriptomics, and functional validation. Translational Oncology 2026; 72 doi: 10.1016/j.tranon.2026.102949
|
| 2 |
Qamar Abuhassan, Hamzeh J. Al-Ameer, Shahad Mohammed Dhiaa Younis, Jasur Rizaev, Makhfirat Kibriyeva, Rasim M. Salih, Mohamed Adil Jaber. Emerging nanoparticle approaches for early detection and therapeutic targeting of pancreatic cancer. Clinica Chimica Acta 2026; 590 doi: 10.1016/j.cca.2026.121102
|
| 3 |
Jun Yu, Yuan Pan, Yi Chen, Zhihui Shu, Lin Ma, Bin Wu, Jingdong Li, Jianshui Li, Chuan Lan. High SOX17 expression is correlated with favorable prognosis and CD8(+) TILs expression in patients with pancreatic cancer after curative resection. Translational Oncology 2026; 70 doi: 10.1016/j.tranon.2026.102859
|
| 4 |
Laura Gehrcken, Jasper Ott, Astrid Van den Eynde, Ho Wa Lau, Dana Liu, Christophe Hermans, Tias Verhezen, Stefanie Peeters, Carole Faghel, Philippe Joye, Gils Roex, Diana Campillo-Davo, Eva Lion, Filipe Elvas, Senada Koljenovic, Jorrit De Waele, Vera Hartman, Geert Roeyen, Hans Prenen, Filip Lardon, Christophe Deben, Evelien Smits, Jonas Van Audenaerde. IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting. Molecular Therapy Oncology 2026; 34(3) doi: 10.1016/j.omton.2026.201316
|
| 5 |
Letian Chen, Zihan Yan, Yuting Rao, Xiaowei Fu, Keyi Fang, Zijian Zhou, Xiaogang Peng, Yeqing Zou. ESCO1 stabilizes NUFIP2 through acetylation–ubiquitination crosstalk to promote pancreatic cancer progression. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1929713
|
| 6 |
İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin, Ece Baydar, Umut Kefeli, Devrim Çabuk, Kazım Uygun. EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer. Medicina 2026; 62(3) doi: 10.3390/medicina62030562
|
| 7 |
Wenjing Ding, Yanchun Fang, Hanmeng Xu, Xinyu Zhang, Chao Li, Yanping Wang, Daoxiang Zhang. VDR Activation Suppresses Pancreatic Cancer Metastasis Through Inhibition of the ERK Signaling Pathway. Cancers 2026; 18(14) doi: 10.3390/cancers18142296
|
| 8 |
Stanisław Surma, Dawid Szkudłapski, Kazimierz Ciechanowski. Hormones in Neuroscience. 2026; doi: 10.1016/B978-0-443-30263-3.00039-7
|
| 9 |
Laura Radoš, Sara Matulić Čubranić, Marin Golčić, Iva Skočilić, Ivana Mikolašević, Andrej Belančić. Contemporary Landscape of Active Clinical Trials in Pancreatic Ductal Adenocarcinoma: A ClinicalTrials.gov—Based Narrative Review with a Scoping Approach. Pharmaceuticals 2026; 19(9) doi: 10.3390/ph19091371
|
| 10 |
Jiaying Cai, Yimin Wu, Xing Jia, Li Yang, Wenjun Yang, Weishan Lu, Zhiye Huang, Yang Pan, Zixuan Fei, Junnan Ru, Jiazheng Zhao, Jue Shen, Taobo Luo, Da Chen, Haihong Yu, Haihan Deng, Jian Zeng, Wenmei Jiang, Leilei Wu. KRAS Mutations in Cancers: From Undruggable Dilemma to Precision Medicine. MedComm 2026; 7(10) doi: 10.1002/mco2.71050
|
| 11 |
Seher Hekimsoy, Aliye Soylu, Mehmet Bayram, Hafize Uzun, Omur Tabak. Evaluation of Pancreatic Lesions: Comparative Analysis of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging. Medicina 2026; 62(5) doi: 10.3390/medicina62050982
|
| 12 |
Yingying Yang, Jie Chen, Shuping Xiao, Xiaoyan Du, Xin Liu. Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A/MMP9 axis: An integrated bioinformatics and experimental study. Pathology - Research and Practice 2026; 288 doi: 10.1016/j.prp.2026.156703
|
| 13 |
Di Meng, Cheng Zhang. RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1948028
|
| 14 |
Pei-Chen Ke, Tsui-Wei Chien. Postoperative symptom burden and factors associated with health-related quality of life within six months after pancreatic cancer surgery in middle-aged and older adults. European Journal of Oncology Nursing 2026; 85 doi: 10.1016/j.ejon.2026.103343
|
| 15 |
Nur Syahirah Haidah Zahid, Aziemah Azizi, Aklimah Mustapa, Syahirah Shahlehi, Masayoshi Arai, Siti Nur Idayu Matusin. Comparative In Vitro Cytotoxicity of Piper betle Leaf Extracts in KRAS G12D-Mutant Pancreatic Cancer Cell Lines. Current Issues in Molecular Biology 2026; 48(9) doi: 10.3390/cimb48090876
|